Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/158160 |
Resumo: | INTRODUCTION: Atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an anticoagulation outpatient clinic; and to describe the profile of this population of patients in terms of risk of stroke, as well as the occurrence of adverse events during the follow-up. METHODS: Retrospective cohort study involving patients of the anticoagulation outpatient clinic of the Department of Internal Medicine at Hospital de Clínicas de Porto Alegre. We evaluated outpatient visits, hospital admissions, and emergency visits from January to December 2011. TTR was calculated using the Rosendaal method. RESULTS: Sixty-three patients were investigated. Their mean age was 74.3±10.9 years. The CHADS2 score was ≥ 4 in 44.5% of the patients; 63.5% of them had a CHA2DS2-VASc score ≥ 5. The TTR was 64.8%. During follow-up, the incidence of overall bleeding was 31.7%, with major and minor bleeding rates of 4.8% and 34.9%, respectively. There were no other complications related to AF or anticoagulation. CONCLUSION: The patients achieved a TTR of 64.8% during follow-up, which is deemed appropriate and in agreement with the literature. Patients had high risk for stroke, and the incidence of minor bleeding was higher than the rate found in the literature, whereas the incidence of major bleeding was similar to the one found in previous studies. |
id |
UFRGS-2_2a3f6250c99fdd446c2caa1ef559552e |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/158160 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Pivatto Junior, FernandoSilva, André Luis Ferreira daRigoni, Lisandra Della CostaSimionato, Bárbara MarinaFuzinatto, FernandaOliveira, Jerônimo de ContoPires, Leonardo MartinsPetry, Roberta CristinaScheffel, Rafael SelbachAmon, Luis Carlos2017-05-18T02:41:13Z20142357-9730http://hdl.handle.net/10183/158160000983375INTRODUCTION: Atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an anticoagulation outpatient clinic; and to describe the profile of this population of patients in terms of risk of stroke, as well as the occurrence of adverse events during the follow-up. METHODS: Retrospective cohort study involving patients of the anticoagulation outpatient clinic of the Department of Internal Medicine at Hospital de Clínicas de Porto Alegre. We evaluated outpatient visits, hospital admissions, and emergency visits from January to December 2011. TTR was calculated using the Rosendaal method. RESULTS: Sixty-three patients were investigated. Their mean age was 74.3±10.9 years. The CHADS2 score was ≥ 4 in 44.5% of the patients; 63.5% of them had a CHA2DS2-VASc score ≥ 5. The TTR was 64.8%. During follow-up, the incidence of overall bleeding was 31.7%, with major and minor bleeding rates of 4.8% and 34.9%, respectively. There were no other complications related to AF or anticoagulation. CONCLUSION: The patients achieved a TTR of 64.8% during follow-up, which is deemed appropriate and in agreement with the literature. Patients had high risk for stroke, and the incidence of minor bleeding was higher than the rate found in the literature, whereas the incidence of major bleeding was similar to the one found in previous studies.application/pdfengClinical and biomedical research. Porto Alegre. Vol. 34, n. 2 (2014), p. 139-144AnticoagulantesVarfarinaFemprocumonaFibrilação atrialAnticoagulantsPhenprocoumonWarfarinAtrial fibrillationInternship and residencyManagement of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinicinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000983375.pdf000983375.pdfTexto completo (inglês)application/pdf365916http://www.lume.ufrgs.br/bitstream/10183/158160/1/000983375.pdf9d67ba1b8c5f135dfd0b1e6126b0b740MD51TEXT000983375.pdf.txt000983375.pdf.txtExtracted Texttext/plain23034http://www.lume.ufrgs.br/bitstream/10183/158160/2/000983375.pdf.txtebad88f997d64f65a63a1d70553b9a8dMD52THUMBNAIL000983375.pdf.jpg000983375.pdf.jpgGenerated Thumbnailimage/jpeg1603http://www.lume.ufrgs.br/bitstream/10183/158160/3/000983375.pdf.jpgd396584040e1507126dc216cb937f21fMD5310183/1581602018-10-30 08:07:22.494oai:www.lume.ufrgs.br:10183/158160Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2018-10-30T11:07:22Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic |
title |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic |
spellingShingle |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic Pivatto Junior, Fernando Anticoagulantes Varfarina Femprocumona Fibrilação atrial Anticoagulants Phenprocoumon Warfarin Atrial fibrillation Internship and residency |
title_short |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic |
title_full |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic |
title_fullStr |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic |
title_full_unstemmed |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic |
title_sort |
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic |
author |
Pivatto Junior, Fernando |
author_facet |
Pivatto Junior, Fernando Silva, André Luis Ferreira da Rigoni, Lisandra Della Costa Simionato, Bárbara Marina Fuzinatto, Fernanda Oliveira, Jerônimo de Conto Pires, Leonardo Martins Petry, Roberta Cristina Scheffel, Rafael Selbach Amon, Luis Carlos |
author_role |
author |
author2 |
Silva, André Luis Ferreira da Rigoni, Lisandra Della Costa Simionato, Bárbara Marina Fuzinatto, Fernanda Oliveira, Jerônimo de Conto Pires, Leonardo Martins Petry, Roberta Cristina Scheffel, Rafael Selbach Amon, Luis Carlos |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Pivatto Junior, Fernando Silva, André Luis Ferreira da Rigoni, Lisandra Della Costa Simionato, Bárbara Marina Fuzinatto, Fernanda Oliveira, Jerônimo de Conto Pires, Leonardo Martins Petry, Roberta Cristina Scheffel, Rafael Selbach Amon, Luis Carlos |
dc.subject.por.fl_str_mv |
Anticoagulantes Varfarina Femprocumona Fibrilação atrial |
topic |
Anticoagulantes Varfarina Femprocumona Fibrilação atrial Anticoagulants Phenprocoumon Warfarin Atrial fibrillation Internship and residency |
dc.subject.eng.fl_str_mv |
Anticoagulants Phenprocoumon Warfarin Atrial fibrillation Internship and residency |
description |
INTRODUCTION: Atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an anticoagulation outpatient clinic; and to describe the profile of this population of patients in terms of risk of stroke, as well as the occurrence of adverse events during the follow-up. METHODS: Retrospective cohort study involving patients of the anticoagulation outpatient clinic of the Department of Internal Medicine at Hospital de Clínicas de Porto Alegre. We evaluated outpatient visits, hospital admissions, and emergency visits from January to December 2011. TTR was calculated using the Rosendaal method. RESULTS: Sixty-three patients were investigated. Their mean age was 74.3±10.9 years. The CHADS2 score was ≥ 4 in 44.5% of the patients; 63.5% of them had a CHA2DS2-VASc score ≥ 5. The TTR was 64.8%. During follow-up, the incidence of overall bleeding was 31.7%, with major and minor bleeding rates of 4.8% and 34.9%, respectively. There were no other complications related to AF or anticoagulation. CONCLUSION: The patients achieved a TTR of 64.8% during follow-up, which is deemed appropriate and in agreement with the literature. Patients had high risk for stroke, and the incidence of minor bleeding was higher than the rate found in the literature, whereas the incidence of major bleeding was similar to the one found in previous studies. |
publishDate |
2014 |
dc.date.issued.fl_str_mv |
2014 |
dc.date.accessioned.fl_str_mv |
2017-05-18T02:41:13Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/other |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/158160 |
dc.identifier.issn.pt_BR.fl_str_mv |
2357-9730 |
dc.identifier.nrb.pt_BR.fl_str_mv |
000983375 |
identifier_str_mv |
2357-9730 000983375 |
url |
http://hdl.handle.net/10183/158160 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Clinical and biomedical research. Porto Alegre. Vol. 34, n. 2 (2014), p. 139-144 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/158160/1/000983375.pdf http://www.lume.ufrgs.br/bitstream/10183/158160/2/000983375.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/158160/3/000983375.pdf.jpg |
bitstream.checksum.fl_str_mv |
9d67ba1b8c5f135dfd0b1e6126b0b740 ebad88f997d64f65a63a1d70553b9a8d d396584040e1507126dc216cb937f21f |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1817724996916609024 |